Eyenovia Inc (EYEN)
0.1019
-0.24
(-70.04%)
USD |
NASDAQ |
Nov 15, 16:00
0.102
0.00 (0.00%)
After-Hours: 20:00
Eyenovia Revenue (Quarterly): 0.0226M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 0.0226M |
March 31, 2024 | 0.005M |
December 31, 2023 | 0.0026M |
September 30, 2023 | 0.0012M |
June 30, 2023 | |
March 31, 2023 | |
December 31, 2022 | |
September 30, 2022 |
Date | Value |
---|---|
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | 10.00M |
September 30, 2021 | |
June 30, 2021 | 2.00M |
March 31, 2021 | 2.00M |
December 31, 2020 | 2.00M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.0012M
Minimum
Sep 2023
10.00M
Maximum
Dec 2021
2.004M
Average
1.011M
Median
Revenue (Quarterly) Benchmarks
TFF Pharmaceuticals Inc | 0.6502M |
Reviva Pharmaceuticals Holdings Inc | -- |
NovaBay Pharmaceuticals Inc | 2.441M |
Palatin Technologies Inc | 0.35M |
iBio Inc | 0.175M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -11.05M |
Total Expenses (Quarterly) | 11.71M |
EPS Diluted (Quarterly) | -0.21 |
Enterprise Value | 19.61M |
Gross Profit Margin (Quarterly) | -2.07K% |
Profit Margin (Quarterly) | -48.86K% |
Earnings Yield | -765.5% |
Normalized Earnings Yield | -784.21 |